Pharmaceutical Business review

Marshall Edwards secures $10 million in public offering

The aggregate proceeds to Marshall Edwards from the sale of shares of common stock will be $10 million before expenses.

The shares are registered under the Securities Act of 1933, as amended, pursuant to an effective shelf registration statement.